Mark J. Pettenati, Ph.D

Associate Professor, Pediatrics-Genetics

Director, Cytogenetics and Molecular Cytogenetics,  MSAFP Laboratory and Program, and Pediatric Genetics Laboratory

Email: pettenat@wfubmc.edu

Education:

Postgraduate: West Virginia University, Ph.D.

Fellowship: Indiana University School of Medicine. 1983

University of Chicago Pritzker School of

Medicine. 1985

Clinical Interests:

Genetics, Cytogenetics, Chromosomes

Publications:

Brownlee NA, Perkins LA, Stewart W, Jackle B, Pettenati MJ, Koty PP, Iskandar SS, Garvin AJ. Recurring translocation (10;17) and deletion (14q) in clear cell sarcoma of the kidney. Arch Pathol Lab Med. 2007 Mar;131(3):446-51.

Chauvenet AR, Martin PL, Devidas M, Linda SB, Bell BA, Kurtzberg J, Pullen J, Pettenati MJ, Carroll AJ, Shuster JJ, Camitta B. Anti-metabolite therapy for lesser risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. Blood. 2007 Apr 18.

Bergman S, Brownlee NA, Geisinger KR, Ward WG, Pettenati MJ, Koty P, Ellis E, Beaty MW, Kilpatrick SE. Diagnostic pitfalls associated with fine-needle aspiration biopsy in a patient with the myxoid variant of monophasic fibrous synovial sarcoma. Diagn Cytopathol. 2006 Nov;34(11):761-7.

Hicks Am, Riedlinger G, Willingham MC, Alexander-Miller MA, Von Kap-Herr C, Pettenati MJ, Sanders AM, Weir HM, Du W, Kim J, Simpson AJ, Old LJ, Cui Z. Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci U S A.   2006 May 16;103(20):7753-8. Epub 2006 May 8.

Connor RF, Hurd D, Pettenati MJ, Koty P, Molnar I. Addition of sargramostim (GM-CSF) to imatinib results in major cytogenetic response in a patient with chronic myeloid leukemia. Leuk Res. 2006 Oct;30(10):1249-52.  [Epub 2006 Mar 31.

Publications:
For a listing of additional publications, refer to PubMed, a service provided by the National Library of Medicine